SlideShare une entreprise Scribd logo
1  sur  14
Estrogen, mTOR, and Metastasis Elizabeth (Lisa) Henske, MD Fox Chase Cancer Center Philadelphia
Estrogen, mTOR, and Metastasis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What is Lymphangiomyomatosis (LAM)? Normal Lung LAM
Crino, Nathanson, and Henske. N Engl J Med 2006 Angiomyolipomas and LAM:  a Working Model B-Raf C-Raf? Estrogen? Mechanism?
Tsc2 -/- MEFs: Tsc2 +/+ MEFs: + + + + serum starved 10 min FBS Phospho-p42/44MAPK TSC2 Activates B-Raf and p42/44 MAPK  32  P-MEK1 B-Raf IP: B-Raf  Active Rheb  B-Raf Im et al. Oncogene 2002 directly binds
Rheb Inhibits B-Raf: Rapamycin Resistant Phospho-S6 Myc-Rheb Myc-Wt-Rheb: Wt-B-Raf: + - + + HEK293 cells Karbowniczek et al.,  J Biol Chem  2004 Phospho- p42/44 MAPK IP: B-Raf B-Raf Activity Rapamycin: + - + + + + Rheb mTOR B-Raf Rapamycin
B-Raf MEK1/2 p42/44 MAPK Proliferation Differentiation Does Rheb also inhibit C-Raf? C-Raf/Raf-1
Whole cell lysate C-Raf: Rheb: 10 min, 20% FBS: + + + + + + + + 24 h, 20 nM Rapamycin + + + + + + + + Phospho-p42/44 MAPK Myc-Rheb IP: Flag Flag-C-Raf Phospho-Ser 338 Rheb inhibits  C-Raf  (as well as B-Raf) Magda Karbowniczek but could not detect interaction 32 P-MEK1 Rheb mTOR B-Raf Rapamycin
Whole cell lysate B-Raf: Rheb: 10 min, 20% FBS: + + + + + + + + 24 h, 20 nM Rapamycin + + + + + + + + HA-B-Raf Rheb Inhibits the Association of B-Raf/C-Raf IP: Magda Karbowniczek Endogenous C-Raf HA-B-Raf IP: C-Raf B-Raf C-Raf Rheb mTOR B-Raf Rapamycin
Rheb Inhibits B-Raf/Ras Binding Magda Karbowniczek HA-B-Raf IP: H-Ras H-Ras B-Raf: Q64L-Rheb: + + + + + + IP:  IgG IP Whole  cell lysate 10 min,  20% FBS: HA-B-Raf Myc-Rheb Tsc2  -/-  MEFs + - - + Control siRNA: Rheb siRNA: Rheb Whole cell lysate IgG B-Raf H-Ras IP: B-Raf
Rheb inhibits B-Raf and C-Raf Kinases:  Model Rheb B-Raf Im et al. Oncogene 2002 Karbowniczek JBC 2004 Karbowniczek JBC 2006 What role, if any, in TSC pathogenesis? B-Raf Ras B-Raf C-Raf
Crino, Nathanson, and Henske. N Engl J Med 2006 Angiomyolipomas and LAM:  a Working Model Estrogen? MCF-7 cells
Estradiol-induced activation of mTOR  in MCF-7 cells  0  15  30  0  15  30  0  15  30 Rapamycin  Wortmannin Phospho-p70S6K (Thr389) Phospho-S6 (Ser235/236) Beta-actin  E2 (min)   Fold: 1  5 Fold: 1  4 p85S6K  Jane Yu “ Non-genomic” or Cytoplasmic Estrogen Signaling
Estrogen Signaling Pathways (James D. Yager, and Nancy E. Davidson,  NEJM 2006)   Genomic pathway:  Gene Transcription E2 activates mTOR:  Rheb dependent? PI3K/Akt and MAPK activation

Contenu connexe

Tendances

Review 4.30.2010
Review 4.30.2010Review 4.30.2010
Review 4.30.2010
Greg
 

Tendances (7)

Carbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care UnitCarbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care Unit
 
Oncogene and Proto-oncogene
Oncogene and Proto-oncogeneOncogene and Proto-oncogene
Oncogene and Proto-oncogene
 
Review 4.30.2010
Review 4.30.2010Review 4.30.2010
Review 4.30.2010
 
Poster: Functional analysis of essential hypothetical proteins of Staphylococ...
Poster: Functional analysis of essential hypothetical proteins of Staphylococ...Poster: Functional analysis of essential hypothetical proteins of Staphylococ...
Poster: Functional analysis of essential hypothetical proteins of Staphylococ...
 
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MD
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MDCarbapenamases. facts detection and concerns by Dr.T.V.Rao MD
Carbapenamases. facts detection and concerns by Dr.T.V.Rao MD
 
Management of Multidrug Resstiant Bacterial Infections management fortis 27....
Management of Multidrug Resstiant Bacterial Infections  management fortis 27....Management of Multidrug Resstiant Bacterial Infections  management fortis 27....
Management of Multidrug Resstiant Bacterial Infections management fortis 27....
 
Adapalene, Etanercept and Triptane. mirfa
Adapalene, Etanercept and Triptane. mirfaAdapalene, Etanercept and Triptane. mirfa
Adapalene, Etanercept and Triptane. mirfa
 

Similaire à Estrogen, mTOR, and Metastasis

Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014
Shreya Dasgupta
 
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Dr.Shuaib Ahmad
 

Similaire à Estrogen, mTOR, and Metastasis (20)

Session 4.3: Backer
Session 4.3: BackerSession 4.3: Backer
Session 4.3: Backer
 
Session 4.3: Backer
Session 4.3: BackerSession 4.3: Backer
Session 4.3: Backer
 
Session 4.3 Backer
Session 4.3 BackerSession 4.3 Backer
Session 4.3 Backer
 
Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014
 
02.2 kaubisch pc
02.2 kaubisch pc02.2 kaubisch pc
02.2 kaubisch pc
 
Session 2.2 Kaubisch
Session 2.2 KaubischSession 2.2 Kaubisch
Session 2.2 Kaubisch
 
Session 2.2: Kaubisch
Session 2.2: KaubischSession 2.2: Kaubisch
Session 2.2: Kaubisch
 
Aditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptxAditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptx
 
Session 2.2: Kaubisch
Session 2.2: KaubischSession 2.2: Kaubisch
Session 2.2: Kaubisch
 
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
 
2016 JHU_NCI Poster
2016 JHU_NCI Poster 2016 JHU_NCI Poster
2016 JHU_NCI Poster
 
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors...
 
report_mmaillard
report_mmaillardreport_mmaillard
report_mmaillard
 
Perspectives of personalized medicine in primary liver cancer by Eric Raymond
Perspectives of personalized medicine in primary liver cancer by Eric RaymondPerspectives of personalized medicine in primary liver cancer by Eric Raymond
Perspectives of personalized medicine in primary liver cancer by Eric Raymond
 
Project Report.pptx
Project Report.pptxProject Report.pptx
Project Report.pptx
 
Pathways of intracellular signal transduction
Pathways of intracellular signal transductionPathways of intracellular signal transduction
Pathways of intracellular signal transduction
 
rli60 project FINAL
rli60 project FINALrli60 project FINAL
rli60 project FINAL
 
Bacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in LiposomesBacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in Liposomes
 
PARP-1 Inhibitors In Oncology
PARP-1 Inhibitors In OncologyPARP-1 Inhibitors In Oncology
PARP-1 Inhibitors In Oncology
 
Regulation of atp7 a gene expression by the grx1 as an inducer in menkes d...
Regulation of atp7 a gene expression by the    grx1 as an inducer in menkes d...Regulation of atp7 a gene expression by the    grx1 as an inducer in menkes d...
Regulation of atp7 a gene expression by the grx1 as an inducer in menkes d...
 

Dernier

Hyatt driving innovation and exceptional customer experiences with FIDO passw...
Hyatt driving innovation and exceptional customer experiences with FIDO passw...Hyatt driving innovation and exceptional customer experiences with FIDO passw...
Hyatt driving innovation and exceptional customer experiences with FIDO passw...
FIDO Alliance
 
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
panagenda
 
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdfBreaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
UK Journal
 
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider  Progress from Awareness to Implementation.pptxTales from a Passkey Provider  Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
FIDO Alliance
 

Dernier (20)

Hyatt driving innovation and exceptional customer experiences with FIDO passw...
Hyatt driving innovation and exceptional customer experiences with FIDO passw...Hyatt driving innovation and exceptional customer experiences with FIDO passw...
Hyatt driving innovation and exceptional customer experiences with FIDO passw...
 
Google I/O Extended 2024 Warsaw
Google I/O Extended 2024 WarsawGoogle I/O Extended 2024 Warsaw
Google I/O Extended 2024 Warsaw
 
Working together SRE & Platform Engineering
Working together SRE & Platform EngineeringWorking together SRE & Platform Engineering
Working together SRE & Platform Engineering
 
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
 
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdfBreaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
 
Human Expert Website Manual WCAG 2.0 2.1 2.2 Audit - Digital Accessibility Au...
Human Expert Website Manual WCAG 2.0 2.1 2.2 Audit - Digital Accessibility Au...Human Expert Website Manual WCAG 2.0 2.1 2.2 Audit - Digital Accessibility Au...
Human Expert Website Manual WCAG 2.0 2.1 2.2 Audit - Digital Accessibility Au...
 
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
Event-Driven Architecture Masterclass: Engineering a Robust, High-performance...
 
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdfLinux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
 
AI mind or machine power point presentation
AI mind or machine power point presentationAI mind or machine power point presentation
AI mind or machine power point presentation
 
Where to Learn More About FDO _ Richard at FIDO Alliance.pdf
Where to Learn More About FDO _ Richard at FIDO Alliance.pdfWhere to Learn More About FDO _ Richard at FIDO Alliance.pdf
Where to Learn More About FDO _ Richard at FIDO Alliance.pdf
 
WebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM PerformanceWebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM Performance
 
Your enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4jYour enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4j
 
WebRTC and SIP not just audio and video @ OpenSIPS 2024
WebRTC and SIP not just audio and video @ OpenSIPS 2024WebRTC and SIP not just audio and video @ OpenSIPS 2024
WebRTC and SIP not just audio and video @ OpenSIPS 2024
 
2024 May Patch Tuesday
2024 May Patch Tuesday2024 May Patch Tuesday
2024 May Patch Tuesday
 
Oauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoftOauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoft
 
Design Guidelines for Passkeys 2024.pptx
Design Guidelines for Passkeys 2024.pptxDesign Guidelines for Passkeys 2024.pptx
Design Guidelines for Passkeys 2024.pptx
 
Introduction to FIDO Authentication and Passkeys.pptx
Introduction to FIDO Authentication and Passkeys.pptxIntroduction to FIDO Authentication and Passkeys.pptx
Introduction to FIDO Authentication and Passkeys.pptx
 
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider  Progress from Awareness to Implementation.pptxTales from a Passkey Provider  Progress from Awareness to Implementation.pptx
Tales from a Passkey Provider Progress from Awareness to Implementation.pptx
 
Event-Driven Architecture Masterclass: Integrating Distributed Data Stores Ac...
Event-Driven Architecture Masterclass: Integrating Distributed Data Stores Ac...Event-Driven Architecture Masterclass: Integrating Distributed Data Stores Ac...
Event-Driven Architecture Masterclass: Integrating Distributed Data Stores Ac...
 
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
 

Estrogen, mTOR, and Metastasis

  • 1. Estrogen, mTOR, and Metastasis Elizabeth (Lisa) Henske, MD Fox Chase Cancer Center Philadelphia
  • 2.
  • 3. What is Lymphangiomyomatosis (LAM)? Normal Lung LAM
  • 4. Crino, Nathanson, and Henske. N Engl J Med 2006 Angiomyolipomas and LAM: a Working Model B-Raf C-Raf? Estrogen? Mechanism?
  • 5. Tsc2 -/- MEFs: Tsc2 +/+ MEFs: + + + + serum starved 10 min FBS Phospho-p42/44MAPK TSC2 Activates B-Raf and p42/44 MAPK 32 P-MEK1 B-Raf IP: B-Raf Active Rheb B-Raf Im et al. Oncogene 2002 directly binds
  • 6. Rheb Inhibits B-Raf: Rapamycin Resistant Phospho-S6 Myc-Rheb Myc-Wt-Rheb: Wt-B-Raf: + - + + HEK293 cells Karbowniczek et al., J Biol Chem 2004 Phospho- p42/44 MAPK IP: B-Raf B-Raf Activity Rapamycin: + - + + + + Rheb mTOR B-Raf Rapamycin
  • 7. B-Raf MEK1/2 p42/44 MAPK Proliferation Differentiation Does Rheb also inhibit C-Raf? C-Raf/Raf-1
  • 8. Whole cell lysate C-Raf: Rheb: 10 min, 20% FBS: + + + + + + + + 24 h, 20 nM Rapamycin + + + + + + + + Phospho-p42/44 MAPK Myc-Rheb IP: Flag Flag-C-Raf Phospho-Ser 338 Rheb inhibits C-Raf (as well as B-Raf) Magda Karbowniczek but could not detect interaction 32 P-MEK1 Rheb mTOR B-Raf Rapamycin
  • 9. Whole cell lysate B-Raf: Rheb: 10 min, 20% FBS: + + + + + + + + 24 h, 20 nM Rapamycin + + + + + + + + HA-B-Raf Rheb Inhibits the Association of B-Raf/C-Raf IP: Magda Karbowniczek Endogenous C-Raf HA-B-Raf IP: C-Raf B-Raf C-Raf Rheb mTOR B-Raf Rapamycin
  • 10. Rheb Inhibits B-Raf/Ras Binding Magda Karbowniczek HA-B-Raf IP: H-Ras H-Ras B-Raf: Q64L-Rheb: + + + + + + IP: IgG IP Whole cell lysate 10 min, 20% FBS: HA-B-Raf Myc-Rheb Tsc2 -/- MEFs + - - + Control siRNA: Rheb siRNA: Rheb Whole cell lysate IgG B-Raf H-Ras IP: B-Raf
  • 11. Rheb inhibits B-Raf and C-Raf Kinases: Model Rheb B-Raf Im et al. Oncogene 2002 Karbowniczek JBC 2004 Karbowniczek JBC 2006 What role, if any, in TSC pathogenesis? B-Raf Ras B-Raf C-Raf
  • 12. Crino, Nathanson, and Henske. N Engl J Med 2006 Angiomyolipomas and LAM: a Working Model Estrogen? MCF-7 cells
  • 13. Estradiol-induced activation of mTOR in MCF-7 cells 0 15 30 0 15 30 0 15 30 Rapamycin Wortmannin Phospho-p70S6K (Thr389) Phospho-S6 (Ser235/236) Beta-actin E2 (min) Fold: 1 5 Fold: 1 4 p85S6K Jane Yu “ Non-genomic” or Cytoplasmic Estrogen Signaling
  • 14. Estrogen Signaling Pathways (James D. Yager, and Nancy E. Davidson, NEJM 2006) Genomic pathway: Gene Transcription E2 activates mTOR: Rheb dependent? PI3K/Akt and MAPK activation